| 名稱 | LNCAP-Luc示蹤細(xì)胞株 |
| 型號(hào) | CBP30195L |
| 報(bào)價(jià) |  |
| 特點(diǎn) | LNCAP-Luc示蹤細(xì)胞株，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 科學(xué)家如何深度破解癌癥基因組的奧秘？
- 上海細(xì)胞庫(kù)——南京科佰生物
- 腫瘤免疫藥靶細(xì)胞模型系列——GITR
- 北京細(xì)胞庫(kù)關(guān)于細(xì)胞存儲(chǔ)的意義了解下
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn)：ADORA2B（腺苷A2B受體）
- 一個(gè)蛋白竟可同時(shí)影響乳腺癌和淋巴癌的形成與擴(kuò)散
- 認(rèn)識(shí)一下北京細(xì)胞庫(kù)的檢測(cè)項(xiàng)目
- LILRB家族細(xì)胞篩選模型
- ATCC細(xì)胞株所用培養(yǎng)基有何要求？
- IL36靶點(diǎn)藥物細(xì)胞篩選模型藥
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
- 詳細(xì)內(nèi)容
LNCAP-Luc示蹤細(xì)胞株 CBP30195L | |
| I. Introduction | |
| Host Cell: | LNCAP (AR positive, p.T868A) |
| Expressed gene: | Luciferase |
| Stability: | 32 passages(in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+15%FBS+1ug/ml puromycin |
| Mycoplasma Status: | Negative |
| Storage: | Liquid nitrogen |
| II. Description of Host Cell Line | |
| Organism: | Homo sapiens, human |
| Tissue: | Prostate |
| Disease: | Prostate carcinoma |
| Morphology: | Adherent fibroblastoid cells growing in aggregates and as single cells |
| Growth Properties: | Mixed adherentsuspension |
| III. Representative Data | |
| |
Figure. Detect Luciferase assay by Promega Bright-Glo Luciferase Assay System. The number of Luminescence signal is 445±18(Mean±SD) on LNCAP cells while 104579±1558(Mean±SD) on LNCAP-Luc cells. | |
| IV. Stablity Test | |
| |
Figure.Stablity test results. LNCAP-Luc cells showed at least 32 passage stability with similar luminescence unit. | |
會(huì)員_a.png)